733043-41-9 Usage
Uses
Used in Pharmaceutical Industry:
3-Hydroxy Anagrelide is used as an antithrombotic agent for the treatment of thrombocytosis, a condition characterized by an abnormally high platelet count in the blood. It helps in reducing the risk of blood clot formation and associated complications.
Used in Research and Development:
3-Hydroxy Anagrelide is also utilized in research and development for studying its effects on platelet aggregation and its potential role in the development of new antithrombotic drugs. Its chemical properties and metabolite status make it a valuable compound for understanding the mechanisms of action and therapeutic potential of Anagrelide and related compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 733043-41-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,3,3,0,4 and 3 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 733043-41:
(8*7)+(7*3)+(6*3)+(5*0)+(4*4)+(3*3)+(2*4)+(1*1)=129
129 % 10 = 9
So 733043-41-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H7Cl2N3O2/c11-5-1-2-6-4(7(5)12)3-15-9(17)8(16)14-10(15)13-6/h1-2,9,17H,3H2,(H,13,14,16)
733043-41-9Relevant articles and documents
QUINAZOLINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF THROMBOCYTHEMIA
-
Page/Page column 21-22, (2010/10/20)
A method for the treatment of thrombocythemia in a subject comprising administering a therapeutically effective amount of compounds having the formulas (I) through (III) or equilibrating forms thereof.
Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
-
Page column 7, (2010/02/15)
In accordance with the present invention there is provided a method for the treatment of peripheral arterial diseases in a host comprising administering a therapeutically effective amount of compounds having the formulas (I) through (III) or analogues thereof.
